Risk of Febrile Convulsions after a Second Immunization against Measles, Mumps and Rubella with MMRV as compared to MMR or MMR+V (MMRV 2nd dose)

24/02/2014
02/07/2024
EU PAS number:
EUPAS5899
Study
Finalised
Documents
Study protocol
Study results
Study results
English (20.62 KB - PDF) View document
Study report
Other information